Jetra Therapeutics is a preclinical biotechnology company developing a novel engineered protein for the treatment of obesity-related liver diseases including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitus (NASH). Jetra Therapeutics is a spin-out of the University of Que...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2019 (5 years) |
Funding status Private |
Company type SME |
Board Observer
Chief Operating Officer
Non Executive Director